REQUEST A DEMO
Total
USD $0.00
Search more companies

Solarpharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Solarpharma Sp. z o.o. Profile Updated: April 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Solarpharma Sp. z o.o. is an enterprise in Poland, with the main office in Legionowo. The company operates in the Pharmaceutical Preparation Manufacturing sector. Solarpharma Sp. z o.o. was incorporated on October 17, 2005. It currently has a total number of 2 (2014) employees. The company’s latest financial report indicates a net sales revenue increase of 194.52% in 2022. Its’ total assets recorded a growth of 38.8%.

Headquarters
Ul. Krucza 63
Legionowo; Mazowieckie; Postal Code: 05-120

Contact Details: Purchase the Solarpharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Solarpharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Solarpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Solarpharma Sp. z o.o. report to view the information.
Incorporation Date:
October 17, 2005
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Solarpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
194.52%
Total operating revenue
-10.08%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
38.8%
Total equity
-20.22%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?